CY1107639T1 - Αλατα του τρυγικου 2-μεθοξυμεθυλο-3-(3,4- διχλωροφαινυλο)-8-αζαδικυkλο[3.2.1] οκτανιου - Google Patents

Αλατα του τρυγικου 2-μεθοξυμεθυλο-3-(3,4- διχλωροφαινυλο)-8-αζαδικυkλο[3.2.1] οκτανιου

Info

Publication number
CY1107639T1
CY1107639T1 CY20071100706T CY071100706T CY1107639T1 CY 1107639 T1 CY1107639 T1 CY 1107639T1 CY 20071100706 T CY20071100706 T CY 20071100706T CY 071100706 T CY071100706 T CY 071100706T CY 1107639 T1 CY1107639 T1 CY 1107639T1
Authority
CY
Cyprus
Prior art keywords
dichlorophenyl
methoxymethyl
octane
salts
azadicyclo
Prior art date
Application number
CY20071100706T
Other languages
English (en)
Inventor
Brian Frostrup
Frank Wätjen
Klaus Snej Jensen
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04766360A external-priority patent/EP1651223B1/en
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of CY1107639T1 publication Critical patent/CY1107639T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Αυτή η εφεύρεση σχετίζεται με νέα τρυγικά άλατα του (lR,2R,3S,5S)-2-μεθοξυμεθυλο-3-(3,4διχλωροφαινυλο)-8-αζαδικυκλο[3.2. 1]οκτανίου όπως τα μονοένυδρα και τα άνυδρα L-τρυγικά (άλατα). Τα άλατα είναι χρήσιμα σαν αναστολείς της επανα-πρόσληψης των νευροδιαβιβαστών (από την ομάδα των) μονοαμινών. Σε άλλες απόψεις, η εφεύρεση σχετίζεται με τη χρήση αυτών των αλάτων σε μια μέθοδο για θεραπεία και με μια φαρμακευτική σύνθεση που περιέχει τα άλατα της εφεύρεσης.
CY20071100706T 2003-07-31 2007-05-24 Αλατα του τρυγικου 2-μεθοξυμεθυλο-3-(3,4- διχλωροφαινυλο)-8-αζαδικυkλο[3.2.1] οκτανιου CY1107639T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301117 2003-07-31
US49409003P 2003-08-12 2003-08-12
EP04766360A EP1651223B1 (en) 2003-07-31 2004-07-29 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts

Publications (1)

Publication Number Publication Date
CY1107639T1 true CY1107639T1 (el) 2013-04-18

Family

ID=34117517

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100706T CY1107639T1 (el) 2003-07-31 2007-05-24 Αλατα του τρυγικου 2-μεθοξυμεθυλο-3-(3,4- διχλωροφαινυλο)-8-αζαδικυkλο[3.2.1] οκτανιου

Country Status (9)

Country Link
KR (1) KR20060054386A (el)
CO (1) CO5640088A2 (el)
CY (1) CY1107639T1 (el)
HK (1) HK1089968A1 (el)
HR (1) HRP20070197T3 (el)
IL (1) IL172576A0 (el)
IS (1) IS2588B (el)
MX (1) MXPA06001050A (el)
NO (1) NO20060934L (el)

Also Published As

Publication number Publication date
HK1089968A1 (en) 2006-12-15
CO5640088A2 (es) 2006-05-31
IS2588B (is) 2010-02-15
IS8330A (is) 2006-02-27
HRP20070197T3 (en) 2007-06-30
IL172576A0 (en) 2006-04-10
MXPA06001050A (es) 2006-04-24
NO20060934L (no) 2006-04-28
KR20060054386A (ko) 2006-05-22

Similar Documents

Publication Publication Date Title
SE0200920D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
TW200613243A (en) Novel compounds
CY1113560T1 (el) Αζαϊνδολια χρησιμα ως αναστολεις των jak και αλλων πρωτεϊνικων κινασων
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
SE0301700D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
CY1111670T1 (el) Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
CY1113069T1 (el) Μεθοδοι παρασκευης συνθεσεων ξηρης σκονης του γλυκοπυρρολικου
HK1079519A1 (en) Furyl compounds
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
SE9901875D0 (sv) Novel compounds
SE0401762D0 (sv) Novel compounds
CY1113533T1 (el) Ετεροαρυλο-υποκατεστημενα παραγωγα κυκλοεξυλο-1,4-διαμινης
TW200639156A (en) New compounds
ATE477256T1 (de) Thienylverbindungen
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1110913T1 (el) Παραγωγα 2-πυρρολιδιν-2-υλο-[1,3,4]-οξαδιαζολης και η χρησιμοποιηση τους σαν αντικαταθλιπτικα
SE0302139D0 (sv) Novel compounds
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors